DELPHARM

Delpharm is a worldwide leader in contract development and manufacturing of medicines for pharmaceutical companies. The company manufactures annually more than one billion units in its manufacturing and development sites providing the majority of available dosage forms on the market: tablets, injectable vials / ampoules / prefilled syringes, freeze dry, suspensions, solutions, ointments and soft gels.The company employs more than 6,500 people and has achieved in 2022 a revenue of €1 billion.